Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 2022
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Cardiovascular System & Hematology (Science Metrix)
- Humans (MeSH)
- Pyrazoles (MeSH)
- Pyridones (MeSH)